Skip to main content

Labour Mergers, Acquisitions and Sales of Business


Executing on a merger, acquisition or sale offers myriad benefits, but carries significant implications that must be carefully considered and accounted for. One such key impact is to your workforce. This impact will be felt on your workforce composition, compensation packages, employment contracts, and your corporation’s pension and benefits obligations.
Subscribe Fasken
Share
  • LinkedIn

Overview

Executing on a merger, acquisition or sale offers myriad benefits, but carries significant implications that must be carefully considered and accounted for. One such key impact is to your workforce. This impact will be felt on your workforce composition, compensation packages, employment contracts, and your corporation’s pension and benefits obligations.

Legislative provisions and common or civil law requirements create obligations and potential liabilities which must be taken into consideration in all forms of commercial transaction, including mergers, acquisitions, sale (in part or whole), and insolvency-related transactions.

Guided by a comprehensive understanding of our clients’ priorities and key objectives for their commercial transaction, our LEHR lawyers work cross-functionally with the Firm’s M&A, insolvency and commercial lawyers to create solutions that offer lasting value for our clients. We are involved in strategic planning, due diligence, negotiation of transaction agreements, and drafting employment contracts and other employment-related agreements. We identify potential risks and design transition strategies and action plans to contain those risks. If or when terminations are unavoidable, we will structure layoffs or redundancies to align with your company’s goals and minimize liability.

Our LEHR team advises local, national and multinational companies in every type of commercial transaction. Whether you are considering a merger, acquisition or sale of your business, contact our team of experienced labour, employment and human rights lawyers to work with you to get the deal done.

Subscribe to our HR Space bulletin to get up-to-date information and trends that will help you make the next business decision with confidence. Call one of our LEHR lawyers for any questions and/or concerns you may have.

Team

Primary Contacts
  • Karen M. Sargeant, Partner | Managing Partner, Ontario, Toronto, ON, +1 416 868 3475, ksargeant@fasken.com
  • Andrew Dixon, Partner | Labour, Employment & Human Rights, Calgary, AB, +1 403 261 8481, adixon@fasken.com
  • Paul Fouche, Partner | Labour, Employment & Human Rights, Johannesburg, +27 11 586 6021, pfouche@fasken.com
  • Rhonda Grintuch, Partner | Labour, Employment & Human Rights, Montréal, QC, +1 514 397 5240, rgrintuch@fasken.com
  • Sophie Arseneault, Partner | Labour, Employment & Human Rights, Ottawa, ON, +1 613 696 6904, sarseneault@fasken.com
  • Laurence Déry, Partner | Labour, Employment & Human Rights, Québec, QC, +1 418 640 2003, ldery@fasken.com

Client Work

  • Twenty31 Consulting acquired by Skift, [Deal - Twenty31 Consulting Inc.], Vancouver-based tourism consulting firm completes sale to a leading global travel intelligence company.
  • Sunnybrook Health Sciences Centre successful in having nurse's termination upheld for falsification of documents and being untruthful during investigation, [Case - Sunnybrook Health Sciences Centre], Internationally recognized health sciences centre and multi-site hospital in Toronto successfully defends termination grievance
  • Fasken successfully represented the Peel District School Board by having grievance dismissed on preliminary basis, [Case - Peel District School Board], Fasken successful in having grievance dismissed on a preliminary basis, arguing that the arbitrator lacked jurisdiction to determine matter exclusively before the WSIB.
  • Skye Bioscience signs arrangement agreement to acquire Emerald Health Therapeutics in a share-for-share transaction, [Deal - Skye Bioscience Inc], Emerald is a Vancouver-based Canadian licensed cannabis producer that is exiting the cannabis sector and pivoting into the pharmaceutical sector. Skye Bioscience is a US-based biopharmaceutical company focused on development of proprietary cannabinoid derivatives for medical treatment of various diseases.
  • Experlogix, LLC Acquires Xpertdoc Technologies, Inc., [Deal - Experlogix, LLC], Experlogix, the leading provider of cloud-based CPQ (Configure, Price, Quote) software, announces the acquisition of Xpertdoc Technologies
  • Aspen Family and Community Network Society amalgamates with the Boys and Girls Club of Calgary, [Deal - Aspen Family and Community Network Society]
  • DaimlerChrysler sells Chrysler Group to Cerberus Capital Management in US$7.4 billion deal, [Deal - DaimlerChrysler AG]
  • Fraser Surrey Docks sold to Macquarie Infrastructure Partners, [Deal - APTL Terminals]
  • Travelzest acquires iTravel2000.com for US$51.5 million, [Deal - Travelzest]

Knowledge

Events

    Subscribe

    Receive email updates from our team

    Subscribe